Cyclic changes in lipoproprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet

被引:54
作者
Muesing, RA
Forman, MR
Graftbard, BI
Beecher, GR
Lanza, E
McAdam, PA
Campbell, WS
Olson, BR
机构
[1] NCI, NIH, CANC PREVENT & CONTROL BRANCH, BETHESDA, MD 20892 USA
[2] GEORGE WASHINGTON UNIV, MED CTR, DEPT MED, LIPID RES CLIN, WASHINGTON, DC 20037 USA
[3] USDA, HUMAN NUTR RES CTR, BELTSVILLE, MD 20705 USA
[4] MOYNAHAN MED CTR, WATERBURY, CT 06702 USA
关键词
D O I
10.1210/jc.81.10.3599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein, apolipoprotein (ape), and hormone levels were measured in 12 healthy women over three consecutive menstrual cycles; one free-living and two under controlled dietary conditions. Serum hormone levels were measured to identify menstrual cycle phases (menses, early follicular, late follicular, and midluteal). After stabilization for one cycle on the controlled diet, ANOVA modeling of the second controlled-diet cycle revealed that low-density lipoprotein (LDL) cholesterol levels in the midluteal phase were significantly lower (by 7%) than in the early follicular phase. High-density lipoprotein (HDL) cholesterol levels during the late follicular phase were higher (by 6%) than menses levels. Differences in the HDL-cholesterol and apoA-I fluctuations resulted in a higher proportion of HDL-cholesterol to apoA-I during the late follicular phase than that during the menses phase. The ratios of LDL cholesterol/HDL cholesterol and apoB/apoA-I in the early follicular phase were greater by 5.6% and 6.0%, respectively, than those in the midluteal phase. Fluctuations in total cholesterol, triglyceride, apoA-I, and apoB did not reach significance. Thus, the cyclic fluctuations of LDL and HDL cholesterol need to be considered in the screening and medical monitoring of women with borderline lipoprotein levels, as well as in the design and the interpretation of results of studies involving premenopausal women.
引用
收藏
页码:3599 / 3603
页数:5
相关论文
共 32 条
[1]   IMPACT OF AGE ON WEIGHT GOALS [J].
ANDRES, R ;
ELAHI, D ;
TOBIN, JD ;
MULLER, DC ;
BRANT, L .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) :1030-1033
[2]   HIGH-DENSITY-LIPOPROTEIN CONCENTRATION IS INCREASED DURING THE OVULATORY PHASE OF THE MENSTRUAL-CYCLE IN HEALTHY-YOUNG WOMEN [J].
AZOGUI, G ;
BENSHLOMO, I ;
ZOHAR, S ;
KOOK, A ;
PRESSER, S ;
AVIRAM, M .
GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (04) :253-257
[3]  
Baird D. T., 1976, ENDOCRINE FUNCTION H, P125
[4]   SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS [J].
BRADLEY, DD ;
WINGERD, J ;
PETITTI, DB ;
KRAUSS, RM ;
RAMCHARAN, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) :17-20
[5]   CORRELATION BETWEEN OVARIAN-STEROIDS AND LIPID FRACTIONS IN RELATION TO AGE IN PREMENOPAUSAL WOMEN [J].
BRIDEAU, NA ;
FOREST, JC ;
LEMAY, A ;
DODIN, S .
CLINICAL ENDOCRINOLOGY, 1992, 37 (05) :437-444
[6]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[7]   LIPID AND HORMONAL PROFILE OF PANAMANIAN WOMEN DURING THE MENSTRUAL-CYCLE [J].
DELEON, RG ;
AUSTIN, KL ;
RICHARDS, L ;
GUERRERO, F .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 39 (03) :219-226
[8]  
FORMAN MR, IN PRESS FLUCTUATION
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]  
GIDEZ LI, 1982, J LIPID RES, V23, P1206